Signs Point To Abbott Joint Venture With India’s Biocon
This article was originally published in The Tan Sheet
Executive Summary
India-based Biocon’s collaborative research arm Syngene, known for its research partnerships with a large set of global companies, likely will develop products up to a certain stage based on leads Abbott provides. Industry sources say they expect Abbott and Biocon are in advanced discussions.
You may also be interested in...
Sanofi Enters India’s Consumer Market With Universal Medicare Buy
Sanofi’s search for high-growth consumer brands in India led to the firm’s Aug. 24 acquisition of Universal Medicare Pvt. Ltd.’s nutraceutical business.
In Brief
FDA releases drug patch guidance
Danone Buys Wockhardt's Nutrition Brands That Abbott Won Then Lost
After several months of discussions, debt-laden Indian drug maker Wockhardt Ltd. managed to sell its growing nutritional business to French food giant Group Danone for a reported $354 million